Document is current

Any future updates will be listed below

HILL: the efficacy and safety of hepatic arterial infusion chemotherapy with the FOLFOX regimen combined with lenvatinib and the PD-L1 inhibitor durvalumab in unresectable hepatocellular carcinoma: a prospective, single-arm, phase 2 clinical trial

Crossref DOI link: https://doi.org/10.1038/s41392-026-02718-0

Published Online: 2026-05-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark